TUCSON, Ariz.--(BUSINESS WIRE)--March 8, 2006--ImaRx Therapeutics, Inc., a biopharmaceutical company developing innovative solutions for stroke and vascular disease, today announced the appointments of Walter Singleton, MA, BM, B.Ch., as chief medical officer, and Lynne Weissberger, Ph.D., as vice president, regulatory affairs, quality assurance & regulatory compliance.
